HIV Pepfar funding cut, Motsoaledi confirms
Motsoaledi said the remaining 7 478 workers are still employed "at least until September".
Minister of Health Aaron Motsoaledi before his keynote address at Sandton Hotel in Johannesburg, 19 March 2025, on the need to prioritise TB during the 'End TB media workshop'. Picture: Nigel Sibanda/The Citizen
More than 8,000 healthcare workers in South Africa have lost their jobs following the withdrawal of United States (US) funding for HIV/Aids programmes, Health Minister Dr Aaron Motsoaledi confirmed on Thursday.
The job losses come as a direct result of US President Donald Trump's January 2025 announcement to withdraw the President's Emergency Plan for AIDS Relief (Pepfar) funding from South Africa's HIV/Aids and TB programmes.
During a media update, Motsoaledi addressed the impact of the funding cuts while countering claims that the country's HIV response has collapsed.
Despite the significant job losses, the health minister emphasised that the vast majority of the HIV/Aids workforce remains intact and operational across affected districts.
'In these 27 districts, there were 271 606 people who are working on the HIV/Aids programmes every day. 15 539 of these were funded by Pepfar , of which, yes, we can confirm today, unfortunately, 8 061 are out of their jobs,' Motsoaledi stated.
Despite these job losses, Motsoaledi emphasised that the remaining healthcare infrastructure continues to function.
'The remaining 7 478 people are still employed because they are funded through Centres for Disease Control and Prevention, or CDC, at least until September this year. So they are still on the job and doing their work as they were normally doing,' he explained.
ALSO READ: Jobs bloodbath as unemployment increases by 1% in first quarter
Motsoaledi counters claims of HIV programme collapse
Motsoaledi expressed concern about recent media narratives suggesting the HIV/Aids programme is collapsing following the funding withdrawal.
'Over the past three weeks, there have been numerous media statements, articles and claims by prominent South Africans who are well known within the HIV/Aids cycle.
'The general thrust of the narrative is that since the announcement on the 20th of January 2025 by President Donald Trump to withdraw funding from Pepfar — the HIV-Aids programme — has collapsed or is on the verge of collapsing, or is inevitably collapsing,' he noted.
The minister challenged what he characterised as a misguided perception about where HIV/Aids work truly takes place.
'It is rather unfortunate. There is a belief that the battle against HIV/Aids can only happen in offices or government buildings, public or private. And if the campaign is not seen there in such buildings, then it means it is not happening,' Motsoaledi remarked.
He emphasised that the real fight against the epidemic happens at the community level.
'We wish to confirm today that the fight against HIV/Aids and TB is in our villages, in our communities and townships and even on the streets of our country. And that is where our focus is, has been, and as it should be.'
ALSO READ: SA funds 90% of its HIV/Aids ARV programme, Motsoaledi reveals amid Pepfar uncertainty
Motsoaledi recalls South Africa's historic HIV crisis
During his address, the health minister reminded attendees of South Africa's history with HIV/Aids, particularly the devastating impact the epidemic had around 2010.
'Many here might have forgotten the real crisis brought about by HIV/Aids, which was the biggest crisis in the valley and happened in South Africa, especially around 2010, where death was an everyday occurrence,' Motsoaledi said.
'We were burying people in large numbers every day. There was a big absenteeism from work. Children were beaten as their mothers were dying.'
He highlighted the severity of the health crisis at its peak: 'By that time, maternal mortality driven by this pandemic had reached a staggering 249 per 100,000 live births. I want to repeat, a staggering 249 women were dying per every 100,000 live births. And the number of children who were born HIV positive was high.'
ALSO READ: Billions' worth of weight loss and diabetes medications reached SA shelves and patients in 2024
South Africa's HIV response strategy
Motsoaledi detailed how South Africa responded to the crisis by implementing an ambitious testing and treatment campaign.
'As a response, we launched the world's biggest HIV-cancelling testing and treatment campaign. We then announced that we're going to test 15 million South Africans in one year as part of that massive campaign,' he said.
The minister recalled that experts were sceptical about the feasibility of this goal.
'I want to remind you that we were never given a chance. Experts from all walks of life, including even the media, never gave us any chance because they thought we're just going to continue along the lines of voluntary counselling and testing, or VCT, as it was called at that time, which relied on passive self-reporting where people will come into health facilities to ask and ask to be tested.'
ALSO READ: Health experts warn of 'huge disaster' as USAID terminates Pepfar HIV funding in SA
HIV/Aids unattainable pipe dream' achieved
He noted that critics had dismissed the government's ambitious target.
'Our target of 15 million people was attacked as an unattainable pipe dream. And we were told that the best that we could achieve was to reach 3 million people only after one year of hard work.'
Despite these challenges, Motsoaledi explained how they pivoted their approach.
'We did not relent. We rather changed the approach from voluntary counselling and testing to what we then called HCD, HIV counselling and testing, meaning we go out in the villages, churches, places of work, communities, sport clubs, royal families, to offer South Africans cancelling and testing, and to put those who are positive on ARV treatment.'
The health minister highlighted the success of this approach: 'And contrary to the naysayers, I wish to remind you that we reached 18 million people in a period of 18 months in that programme.'
Despite the recent funding cuts from Pepfar, Motsoaledi emphasised that South Africa still maintains a substantial HIV/AIDS workforce, with 263,354 healthcare workers continuing to deliver critical services in previously Pepfar-funded districts.
He said those previously supported under Pepfar were absorbed into public clinics and continue to receive uninterrupted treatment.
NOW READ: Inside SA government's confused response to the USAid funding crisis
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
IOL News
10 hours ago
- IOL News
New healthcare service launched for taxi drivers in Orange Farm
Ribbon cutting at the Mpathy Clinic opening in Orange Farm Image: Supplied This Men's Health Month, the question of who looks after those who drive the heart of South Africa's transport system has been strikingly addressed. In a collaborative effort, Rhiza Babuyile, a prominent non-profit organisation, has teamed up with the Department of Health, Johannesburg Health District Services, and the Orange Farm United Taxi Association (OFUTA) to launch a much-needed healthcare initiative specifically for taxi drivers. The Mpathy Clinic officially opened its doors at one of Orange Farm's busiest taxi ranks, signalling a valuable addition to the community that prioritises the health needs of one of the most hardworking groups in South Africa. 'Taxi drivers avoid going to a clinic because their working conditions simply don't allow them the time to wait in long queues. With this new service, they'll get treatment fast. Quick in and out, no long lines. It's a quality service, built around their reality,' stated Lerato Seheri, Healthcare Manager at Rhiza Holdings. The convenience of the newly launched clinic is a game changer for taxi drivers, who often work long hours under pressure. According to Seheri, the clinic is tailored specifically to accommodate their busy schedules, with consultation fees ranging between R100 and R300, a substantial saving compared to private healthcare costs. 'This clinic meets them where they are and provides them with care without disrupting their day,' she added. The newly launched Mpathy Clinic in Orange Farm Image: Supplied The initiative aligns with South Africa's national 'Closing the Gap' ART Campaign, which aims to identify and support the 1.1 million individuals living with HIV who know their status but have not yet accessed treatment. Seheri highlighted this as critical, remarking, 'Men are significantly less likely than women to engage with routine health services, often leading to late diagnoses of health conditions that could have been manageable or preventable.' Mmakobo Gaegake, Programme Manager for HIV, AIDS, Sexually Transmitted Infections, and Tuberculosis (HAST), echoed these sentiments, underscoring the significance of providing health services at the taxi rank.
Mail & Guardian
12 hours ago
- Mail & Guardian
Motsoaledi's big HIV treatment jump: Is it true?
How close is South Africa to meeting its HIV treatment goals? We look at the numbers. (NIAID/Wikimedia) Numbers are powerful. They can also be dangerous if not used correctly. When the The health department's goal is In his words, the department has reached 'more than 50% of the target' they set out to achieve by the end of the year. If that gap is closed, South Africa would have met two of the three But knowing exactly how much the gap is closing is tricky, because people who know they have HIV may start and stop and then restart treatment again later — sometimes several times — during the course of their care. So, many of the 520 700 previously diagnosed people Motsoaledi says are now on medication could, at least in theory, very well be people who are counted repeatedly as they cycle in and out of treatment. But because the patient information system isn't digitally centralised — most clinics still keep track of their clients on paper, which means different facilities can't easily access one another's records — someone who stops treatment at one clinic can easily be counted as a new start at another, rather than a restart. The set of UN targets aim for 95% of people in a country with HIV to know their diagnosis, 95% of those being on treatment and 95% of those taking medication having such low levels of virus in their bodies that they can't infect someone through sex. 'The reason that we [were] able to reach half a million within a short space of time, was because of weekly check-in meetings with provinces, where reports that come from the ground are verified in the presence of all provincial colleagues before they are regarded as final figures for reporting,' said the minister. But simply counting better isn't the same as doing better, and critics called the reported progress Why? Because for the past few years, the number of people with HIV who have gone on treatment has Moreover, that was while treatment programmes had funding and US-backed money for HIV projects was in place. So now, at a time of We dive into the data to get a sense of what the numbers really mean. Mind the gap In 2021, South Africa was about 1.2-million people short of its 95%-treatment goal; by 2025 the shortfall will likely be 990 000. That means that the gap — that is, the difference between where the country actually is and where it wants to be when it comes to HIV treatment — has closed by about 210 000. So there's been progress, but it's been slow: in total, only about 700 000 more people are on HIV medication today than five years ago. 'Getting that last one million or so people on treatment is not simple,' says Kate Rees, public health specialist at the Sometimes people miss an appointment to get a refill of their medicine because they can't afford to take time off work to go to the clinic or they might have moved to another province or district and so they don't go back to the facility where they first got their prescription, she explains. The longer the interruption lasts, the more hesitant people are to go back, says Rees, because they dread Says Rees: 'The health service expects people to be very rigid with their appointments, but life just is not like that.' Slow progress To get a sense of the progress towards meeting the UN's second target in its 95-95-95 cascade, it's best to look at the difference in the total number of people on HIV treatment from year to year, says Leigh Johnson, one of the lead developers of the Although the number of people on medication is increasing, the number grows less and less each year. For example, in 2020, about 291 000 more people were on treatment than in 2019. By 2021, though, the number had grown only by about 225 000. Current forecasts from the model are that the total number of people on treatment will grow by only about 160 000 this year. But that's based on programmes running like they have up to now — and with recent upsets because of US funding cuts, it may be an unreasonable assumption, Johnson says. Part of the reason for the small net gain every year, is that although many people sign up for medication in a year, many also stop coming back to get their scripts refilled. Of those who drop out of treatment, some might choose to restart within a couple of months again, while others may pause their treatment for more than a year. In 2023, for example, roughly 793 500 people who had been on treatment before weren't any longer, but about 728 000 who received medication were restarters, Thembisa numbers show. So even though some people who stop taking their medication might not restart — or restart quickly — the total number who are on treatment still grows; it's just slow-going. This means getting a handle on how close to — or far from — the 95%-treatment mark South Africa is, is more dynamic than simple addition. Stops, starts and restarts 'There will always be people who interrupt their treatment,' says Rees. 'It's not possible to keep everyone perfectly in the system all the time — that's life.' But what's important, she says, is to make those pauses as short as possible by helping people to get back on medication quickly and easily — without judgment. Gesine Meyer-Rath agrees. She's a health economist at Data in the Thembisa model shows that over the years, the number of people starting medication for the first time — in other words, those who have never been on treatment before — has shrunk, but at the same time counts of restarters have grown. Her group's analyses have shown that honing in on keeping people on HIV treatment is the best way to go — But to plan sensibly, she explains, policymakers should know how many people are first-time starters, how many pause treatment but then restart, and how many stop and don't come back at all. 'The more detail programme planners have in the data, the better,' she says. 'The [government's] This is exactly where things can become tricky in future if the holes left by the US funding cuts aren't plugged. Because of the US's aid withdrawal, about 40% of South Africa's HIV data capturers will likely have lost their jobs by September, Says Meyer-Rath: 'The less data we have, the more we're flying blind, which leaves space for bickering over the data that is still there.' This story was produced by the . Sign up for the .
The Citizen
13 hours ago
- The Citizen
SA highlights strong surveillance as new COVID variant spreads across Asia
South Africa is closely monitoring the emergence of a new COVID-19 variant, known as Nimbus or NB.1.8.1, associated with a rise in cases in certain regions of Asia. This is according to Health Minister Dr Aaron Motsoaledi, who addressed the 4th Health Working Group meeting of the Group of 20 (G20), which is underway in Johannesburg. Motsoaledi said the World Health Organisation (WHO) has designated this 'a variant under monitoring' due to its growing presence. India is the latest country to experience a surge in new COVID-19 cases due to the emergence of the new variant, NB.1.8.1. According to the Independent, infections have been confirmed in several Asian countries, including Thailand, Indonesia and China. In addition, the United Kingdom Health Security Agency reported the first 13 cases of this variant in England last week. 'I wish to reassure this esteemed gathering that South Africa has robust surveillance systems in place. 'Our National Institute for Communicable Diseases (NICD) manages a comprehensive sentinel surveillance programme that systematically tests for key respiratory viruses, including SARS-CoV-2, influenza, and RSV. Currently, our data show very low SARS-CoV-2 activity,' Motsoaledi explained. South Africa is currently experiencing a seasonal rise in influenza, but the country is well-prepared to manage the situation, he said. 'Crucially, the new variant remains a descendant of the Omicron lineage. This means that current recommendations for updated SARS-CoV-2 vaccines are still effective. Therefore, at this stage, no specific new public health actions are required from the public.' Motsoaledi said government continues to promote good hygiene practices, including handwashing, covering coughs, and staying home when feeling unwell. 'These simple measures are effective in reducing the spread of all respiratory illnesses. We will continue to monitor the situation closely through our established networks and will report any significant changes.' Meanwhile, he called on the attendees of the meeting to work together with 'renewed urgency and unwavering resolve'. 'Let us build a future where solidarity, equity, and cooperation are the cornerstones of our global health architecture.' The week-long Health Working Group meeting began on Tuesday and will conclude on Friday. It brings together health leaders, experts, and policymakers from the world's largest economies, invited nations, and international organisations. The plenary sessions will build on lessons learned from the COVID-19 pandemic and address ongoing barriers to accessing countermeasures, particularly in low- and middle-income countries. There will be a focus on prioritising the expansion of local and regional manufacturing capacity, especially in regions like Africa. Delegates will also explore opportunities for technology transfer, sustainable financing, and regulatory alignment to ensure timely and equitable access to life-saving tools during health emergencies. –
